Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Esophageal Squamous Cell Carcinoma × pegfilgrastim × 90 days × Clear all

Sponsor

Conditions

Lymphoma, Large B-Cell, Diffuse 4 Breast Neoplasms 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Hodgkin Disease 2 Burkitt Lymphoma 2 Triple Negative Breast Neoplasms 1 Teratoma 1 Sarcoma, Ewing 1 Sarcoma 1 Rhabdomyosarcoma 1 Renal Pelvis and Ureter Urothelial Carcinoma 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Pain 1 Osteosarcoma 1 Neoplasms 1 Medulloblastoma 1 Lymphoma 1 Leukemia, Myeloid, Acute 1 Leukemia, Myeloid, Accelerated Phase 1 Infiltrating Bladder Urothelial Carcinoma 1 Heart Failure 1 Glioma 1 Fallopian Tube Neoplasms 1 Desmoplastic Small Round Cell Tumor 1 Dendritic Cell Sarcoma, Interdigitating 1 Choriocarcinoma 1 Central Nervous System Neoplasms 1 Cardiotoxicity 1 Carcinoma, Ovarian Epithelial 1 Carcinoma, Embryonal 1

Interventions

Cisplatin 11 pembrolizumab 8 Paclitaxel 7 Drug Therapy 6 Irinotecan 4 Fluorouracil 4 Carboplatin 4 toripalimab 3 Radiotherapy 3 tislelizumab 2 nimotuzumab 2 Oxaliplatin 2 Nivolumab 2 Levoleucovorin 2 Leucovorin 2 Docetaxel 2 Albumin-Bound Paclitaxel 2 130-nm albumin-bound paclitaxel 2 regorafenib 1 osimertinib 1 nedaplatin 1 lenvatinib 1 futibatinib 1 durvalumab 1 camrelizumab 1 atezolizumab 1 aflibercept 1 Tiragolumab 1 Surgical Procedures, Operative 1 Radiation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡